ADC Therapeutics (ADCT) Inventory Average (2021 - 2026)
ADC Therapeutics (ADCT) posted Inventory Average of $4.5 million for Q1 2026, down 59.69% sequentially from $11.1 million in Q4 2025, and down 54.51% YoY from $9.8 million in Q1 2025.
ADC Therapeutics (ADCT) Inventory Average (2021 - 2026) Analysis & Trends
ADC Therapeutics has reported Inventory Average for 6 years, with the latest figure at $4.5 million in Q1 2026.
- Quarterly Inventory Average fell 54.51% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 million (down 54.51% YoY) and the FY2025 annual result came in at $3.2 million, down 65.08% from the prior year.
- Inventory Average eased to $4.5 million in Q1 2026 per ADCT's latest filing, from $11.1 million in the prior quarter.
- Over five years, Inventory Average peaked at $21.1 million in Q3 2023 and troughed at $4.5 million in Q1 2026.
- A 5-year average of $14.5 million and a median of $15.2 million in 2022 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2026: Inventory Average soared 93.28% in 2022, then tumbled 54.51% in 2026.
- Over 5 years, Inventory Average stood at $13.9 million in 2022, then jumped by 39.86% to $19.5 million in 2023, then slumped by 52.9% to $9.2 million in 2024, then climbed by 21.3% to $11.1 million in 2025, then plunged by 59.69% to $4.5 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $4.5 million, $11.1 million, and $17.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | ADC Therapeutics | 148.95 Mn | -70.15 Mn | 17.14 Mn | 4.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.85 Mn |
| Mar 31, 2026 | 4.48 Mn |
| Dec 31, 2025 | 11.11 Mn |
| Sep 30, 2025 | 17.90 Mn |
| Jun 30, 2025 | 17.61 Mn |
| Mar 31, 2025 | 9.85 Mn |
| Dec 31, 2024 | 9.16 Mn |
| Sep 30, 2024 | 15.63 Mn |
| Jun 30, 2024 | 15.59 Mn |
| Mar 31, 2024 | 16.09 Mn |
| Dec 31, 2023 | 19.45 Mn |
| Sep 30, 2023 | 21.08 Mn |
| Jun 30, 2023 | 18.84 Mn |
| Mar 31, 2023 | 15.16 Mn |
| Dec 31, 2022 | 13.91 Mn |
| Sep 30, 2022 | 15.20 Mn |
| Jun 30, 2022 | 13.24 Mn |
| Mar 31, 2022 | 11.48 Mn |
| Dec 31, 2021 | 9.57 Mn |
| Sep 30, 2021 | 7.86 Mn |